Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sette

Showing results (11-20 of 299) with videos related to

Pageof 30
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 27, 2001
Customized versus universal scoring functions: application to class I MHC-peptide binding free energy predictionsA Logean, A Sette, D Rognan
International Journal of Bio-Medical Computing|May 1, 1988
A basic library of microcomputer programs to obtain immunologically relevant information from protein sequencesA Sette, G Doria, L Adorini
Current Opinion in Biotechnology|December 1, 1991
Major histocompatibility complex binding peptides: a target for therapeutic developmentA Sette, P Wentworth, H M Grey
Scientific American|November 1, 1989
How T cells see antigenH M Grey, A Sette, S Buus
Annals of the New York Academy of Sciences|January 1, 1988
Structural characteristics of peptides required for their interaction with IAdH M Grey, A Sette, S Buus
Clinical Immunology and Immunopathology|September 1, 1995
Interaction of antigenic peptides with MHC and TCR moleculesA Sette, J Alexander, H M Grey
Immunological Reviews|August 1, 1987
The interaction between protein-derived immunogenic peptides and IaS Buus, A Sette, H M Grey
Science (New York, N.Y.)|August 31, 1990
The minimal number of class II MHC-antigen complexes needed for T cell activationS Demotz, H M Grey, A Sette
Seminars in Cancer Biology|December 1, 1995
Epitope selection and development of peptide based vaccines to treat cancerE Celis, A Sette, H M Grey
Clinical Immunology and Immunopathology|November 1, 1989
Biologic significance and therapeutic implications of antigen/MHC interactionsH M Grey, A Sette, A Lamont
Pageof 30

Showing results (11-20 of 299) with videos related to

Sort By:
Pageof 30
Bioorganic & Medicinal Chemistry Letters|March 27, 2001
Customized versus universal scoring functions: application to class I MHC-peptide binding free energy predictionsA Logean, A Sette, D Rognan
International Journal of Bio-Medical Computing|May 1, 1988
A basic library of microcomputer programs to obtain immunologically relevant information from protein sequencesA Sette, G Doria, L Adorini
Current Opinion in Biotechnology|December 1, 1991
Major histocompatibility complex binding peptides: a target for therapeutic developmentA Sette, P Wentworth, H M Grey
Scientific American|November 1, 1989
How T cells see antigenH M Grey, A Sette, S Buus
Annals of the New York Academy of Sciences|January 1, 1988
Structural characteristics of peptides required for their interaction with IAdH M Grey, A Sette, S Buus
Clinical Immunology and Immunopathology|September 1, 1995
Interaction of antigenic peptides with MHC and TCR moleculesA Sette, J Alexander, H M Grey
Immunological Reviews|August 1, 1987
The interaction between protein-derived immunogenic peptides and IaS Buus, A Sette, H M Grey
Science (New York, N.Y.)|August 31, 1990
The minimal number of class II MHC-antigen complexes needed for T cell activationS Demotz, H M Grey, A Sette
Seminars in Cancer Biology|December 1, 1995
Epitope selection and development of peptide based vaccines to treat cancerE Celis, A Sette, H M Grey
Clinical Immunology and Immunopathology|November 1, 1989
Biologic significance and therapeutic implications of antigen/MHC interactionsH M Grey, A Sette, A Lamont
Pageof 30